GLP-1 drugs like Ozempic have swept the world as effective therapies for far more than their original target of diabetes. Widely prescribed and wildly popular,
Deaths from cancer continue to fall in the United States, the American Cancer Society reported Thursday, but within that encouraging trend is a disturbing shift
The body mass index is not going away, a new report suggests, but it could be demoted to just a first step in making a
Life was getting better for Carlos Campos, 72, a retired machinist who lives with his wife and daughter in Tukwila, Wash. Diagnosed about 20 years
Just over a year ago the PREVENT calculator to predict cardiovascular risk was released by the American Heart Association. It was acclaimed for improving on
After nearly two years of review and discussion, scientists charged with advising federal health and agriculture agencies on the next edition of dietary guidelines issued
CHICAGO — Lipoprotein(a) is a risk factor for cardiovascular disease you may not hear about in your annual physical. Like LDL, or “bad” cholesterol, too
CHICAGO — This year’s scientific sessions on the latest research in cardiovascular disease began not with the buzzy new obesity drugs but with a sobering
CHICAGO — In his presidential address to the American Heart Association on Sunday, Keith Churchwell, a clinical cardiologist and past hospital administrator, started right at
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. I’m back on the newsletter